Korea Exchange · Healthcare
HANDOK stock from India: price, numbers and tax
HANDOK (002390) is not currently available to trade on Paasa; this guide covers the price, the numbers and the Indian tax treatment.
By Paasa · Updated
HANDOK at a glance
- Price
- ₩8,600.00-₩50.00 (0.58%)
- Market cap
- ₩111.72B
- Day range
- ₩8,520.00 – ₩8,750.00
- P/E
- -11.33
- Dividend yield
- 2.33%
- Volume
- 2.66K
- 1 month
- -8.99%
- 6 months
- -17.07%
- YTD
- -23.21%
- 1 year
- -27.43%
- 5 years
- -63.71%
HANDOK statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | ₩535.1B | ₩507.4B | ₩522.7B | ₩543.8B | ₩517.6B |
| Gross profit | ₩144.5B | ₩157.4B | ₩151.4B | ₩173.7B | ₩167.5B |
| Operating income | ₩3.3B | ₩538.5M | ₩12.6B | ₩19.5B | ₩17.6B |
| Net income | −₩2.2B | −₩52.6B | −₩28.8B | ₩10.7B | ₩3.3B |
| Earnings per share | −₩162.61 | −₩3,822.69 | −₩2,091.39 | ₩775.88 | ₩239.28 |
| EBITDA | ₩26.8B | −₩20.8B | ₩2.8B | ₩50.3B | ₩49.4B |
| Total assets | ₩790.8B | ₩788.6B | ₩790.3B | ₩871.1B | ₩841.6B |
| Total debt | ₩379.4B | ₩373.4B | ₩300.0B | ₩298.3B | ₩258.4B |
| Cash and short-term investments | ₩28.1B | ₩56.0B | ₩20.1B | ₩39.8B | ₩35.4B |
| Shareholders' equity | ₩276.6B | ₩287.3B | ₩338.7B | ₩379.8B | ₩384.0B |
| Operating cash flow | ₩4.0B | −₩2.8B | ₩36.0B | ₩30.5B | ₩37.2B |
| Free cash flow | −₩9.9B | −₩22.2B | ₩9.8B | −₩13.2B | −₩6.2B |
| Capital expenditure | −₩13.9B | −₩19.4B | −₩26.2B | −₩43.7B | −₩43.5B |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in KRW; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Yuhan | 000100.KS | ₩73,100.00 | ₩5.38T |
| Dong-A Socio | 000640.KS | ₩93,000.00 | ₩626.13B |
| JW Pharmaceutical | 001060.KS | ₩26,350.00 | ₩608.52B |
| Chong Kun Dang | 001630.KS | ₩37,250.00 | ₩177.33B |
| Dongwha Pharm | 000020.KS | ₩5,360.00 | ₩148.57B |
Peers as grouped by the data provider. This is not an investment recommendation.
Why invest in HANDOK from India
What HANDOK does
HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. HANDOK operates in the Medical - Pharmaceuticals industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
What tax do I pay in India when I sell HANDOK shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the KRW/INR rate on the day you bought and the day you sold, so the currency move is part of the gain.